Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion ( in a high-titered human serum could be recovered from the octapeptide column, indicating that a significant fraction of these anti-parasite antibodies react with epitopes associated with the octapeptide. Furthermore, the human octapeptidereactive antibodies very efficiently inhibited merozoite reinvasion into erythrocytes in vitro. Similarly purified rabbit antibodies also significantly inhibited reinvasion. Our results suggest that the C-terminal segment of repeated peptides in Pf 155 is a major antigenic region of the molecule and may contain target sites for protective immunity in P. fakiparum malaria.
hemocyanine or tetanus toxoid formed antibodies against the octapeptide. These antibodies reacted with Pf 155 as detected by immunoblotting or a modified immunofluorescence assay. Sera from humans exposed to P. falciparum also contained antibodies binding to the octapeptide in a dot-blot immunoassay. Their anti-octapeptide titers were correlated with their immunofluorescence titers in the assay detecting Pf 155 and other parasite antigens in the membrane of infected erythrocytes. Human octapeptide-reactive antibodies were isolated on an affinity column with the octapeptide conjugated to bovine serum albumin as ligand. These human antibodies reacted with Pf 155 in immunoblotting and strongly stained the surface of infected erythrocytes in the modified immunofluorescence assay. Approximately 20% of this immunofluorescence activity in a high-titered human serum could be recovered from the octapeptide column, indicating that a significant fraction of these anti-parasite antibodies react with epitopes associated with the octapeptide. Furthermore, the human octapeptidereactive antibodies very efficiently inhibited merozoite reinvasion into erythrocytes in vitro. Similarly purified rabbit antibodies also significantly inhibited reinvasion. Our results suggest that the C-terminal segment of repeated peptides in Pf 155 is a major antigenic region of the molecule and may contain target sites for protective immunity in P. fakiparum malaria.
In the light of the worldwide increase of Plasmodium falciparum malaria, the development of a vaccine against the disease is of high priority. Antigens involved in protective immunity against P. falciparum sporozoites (1, 2) or in transmission-blocking immunity against the gametes of this parasite (3) have been identified. Certain antigens from the antigenically complex asexual blood stages are also being assessed for their possible involvement in protective immunity against these stages (4) (5) (6) (7) (8) . We recently identified one P. falciparum antigen of Mr 155,000, designated Pf 155, deposited in the erythrocyte (RBC) membrane during merozoite invasion (9, 10) . Human antibodies to this antigen were extremely efficient in inhibiting P.falciparum reinvasion in in vitro cultures (10, 11) . Furthermore, in children living in a holoendemic area of Africa, a correlation was found between high levels of antibodies to Pf 155 and acquired P. falciparum immunity (9, 12) . As the antigen was shown to bind to glycophorin, was heat stable and poor in methionine (9, 13) , it is probably identical with the glycophorin-binding P. falciparum protein of Mr 155,000 described by Perkins (14) . Pf 155 appears also to be the same as RESA (ring-infected erythrocyte surface antigen), a P. falciparum antigen recently described by Coppel et al. (15) . In its C-terminal part, this antigen was shown to comprise a region of repeating subunits of 8, 4, and 3 amino acids (15) . Another block of repeated 10-and 11-amino acid sequences is in the N-terminal part and displays some immunological cross-reactivity with the Cterminal repeat region (16) .
In this study we used a synthetic peptide, corresponding to the 8-amino acid repeat of RESA (15) , for immunization of rabbits and for isolation by affinity chromatography of human immunoglobulins binding to the peptide. Immunoblotting and immunofluorescence (IF) were used to study the reactivity of the anti-peptide antibodies with P. falciparum antigens. The capacity of both rabbit and human antibodies to inhibit merozoite reinvasion was studied in P. falciparum in vitro cultures.
MATERIALS AND METHODS
Parasite material was from in vitro cultures of the Tanzanian P. falciparum strain F32. For antigen analysis, merozoiteenriched fractions or, alternatively, supernatants from spent culture medium were prepared and processed as described (10) .
Human sera were from Liberian donors (Kinon, IS-7, IS-8, and L-30) living in a P. falciparum holoendemic area (17) or from South American donors (AM, ASF, MV, JOR, and FG) living in an endemic area of Colombia (for details, see refs. 10 and 11).
Synthetic Peptide. The octapeptide Glu-Glu-Asn-Val-GluHis-Asp-Ala was synthesized by the standard method of Merrifield (18) Elution of Antibodies from RBC Monolayers. Antibodies binding to the surface of infected RBC (GA-fixed and air-dried) were eluted with 0.2 M glycine buffer (pH 2.8) as described (10) . Dot Immunoblotting. Two ,ul of octapeptide-BSA conjugate (0.5 mg of octapeptide per ml) were applied onto nitrocellulose strips (Bio-Rad). After being dried, the nitrocellulose was incubated in 3% (wt/vol) BSA in PBS for at least 2 hr and then for 2 hr with test serum diluted in PBS containing 1% BSA, 0.1% Triton X-100, and 0.02% NaN3 (PBS-T). The nitrocellulose was washed 5 times for 5 min in PBS-T containing 0.2% BSA. It was then incubated for another 2 hr with the proper anti-immunoglobulin antibodies conjugated to alkaline phosphatase (20) diluted in PBS-T containing 1% BSA. After the washing procedure was repeated, the nitrocellulose was stained for alkaline phosphatase (21) . For detection of antibodies reacting with protein residues modified by the coupling reagent, BSA treated with GA was used as control antigen.
Other Procedures. Immunoblotting of merozoite polypeptides separated by NaDodSO4/PAGE (reducing conditions) was performed as described (10, 21) .
Indirect IF of GA-fixed and air-dried monolayers of P. falciparum-infected erythrocytes was performed as described by Perlmann et al. (10) . Inhibition of the IF was assayed as described (10) by using either native octapeptide or octapeptide-BSA at concentrations corresponding to 2-200 ,g of octapeptide per ml. When octapeptide-BSA was used, GA-treated BSA was the control antigen.
Inhibition of merozoite reinvasion in P. falciparum in vitro cultures was performed with serum or isolated IgG fractions as described (11) .
RESULTS
The octapeptide Glu-Glu-Asn-Val-Glu-His-Asp-Ala was synthesized and analyzed by HPLC (Fig. 1) . One main peak containing 62% of the material and two minor peaks containing 3% and 23% of the material were obtained. Amino acid analysis of these peaks showed that they had the expected composition of the octapeptide (Table 1) ; however, the composition of the two minor peaks deviated slightly. Antigenic aspects of these three peaks will be dealt with below. The whole unseparated octapeptide preparation was used in the following experiments ifnot otherwise mentioned.
Rabbits were immunized with the octapeptide conjugated with either KLH or TT, and the sera were then tested for octapeptide-reactive antibodies in a dot-immunoblotting assay. Both sera reacted with an octapeptide-BSA conjugate, while the preimmune sera were negative. When titrated, the anti-octapeptide-KLH antiserum reacted with octapeptide-BSA up to a dilution of 1:6,400, whereas the end-point titers of anti-octapeptide-TT was 1:12,800. The anti-octapeptide-KLH reacted weakly with GA-treated BSA (1:100), indicating that it contained only low amounts of antibodies reactive with protein residues modified by the coupling reagent (22) . In contrast, the antiserum to octapeptide-TT reacted significantly with GA-treated BSA, although at lower titers than with octapeptide-BSA.
The antisera were tested for reactivity with P. falciparum polypeptides by means of immunoblotting after NaDodSO4/ PAGE of merozoite extracts. When probed with human immune serum, at least 20 bands, representing parasite antigens, appear on the blots (10, 11) . In contrast, when probed with the rabbit anti-octapeptide antisera, the only strongly stained band was Pf 155. In addition, a few polypeptides of lower molecular weight were weakly stained (Fig. 2) . The same Mr 155,000 polypeptide was the major stained band when merozoite extracts or soluble parasite components from culture supernatants were used as antigen (10, 13) . The weakly stained bands included primarily polypeptides of Mrs 135,000 and 120,000, previously shown to be antigenically related to Pf 155 (13) . The anti-octapeptide-KLH and anti-octapeptide-TT antisera gave identical results in this assay (not shown). (Table 2 ). Ten normal human sera so treated did not react with octapeptide-BSA at dilutions of >1:100 (not shown).
The octapeptide-reactive antibodies of the serum from a P. falciparum immune Liberian (Kinon) were isolated by affin- ity chromatography with octapeptide-BSA as ligand on Sepharose 4B beads. Approximately 0.15% of the serum IgG applied to the column could be eluted from the adsorbent with 3 M KSCN. When calculated on the basis of the IF titers, the total serum volume added to the octapeptide column, and the volume ofthe eluates, the anti-octapeptide activity recovered amounted to =20% of the antibody activity giving rise to surface IF of infected RBC (13%, 20%, and 25%, respectively; three experiments). As -60% of this activity passed through the octapeptide columns, the total recovery of IF activity ranged from 70% to 85%. Similar experiments with the rabbit anti-octapeptide-KLH antiserum indicated that -10% of the IF activity could be eluted from the octapeptide column. However, in this case the fraction passing the column had no antibody activity. Addition of an excess of octapeptide or octapeptide-BSA (200 ,ug of octapeptide per ml) in the IF assay had no inhibitory effect on the staining with the human antibodies eluted from the octapeptide column. In contrast, the surface IF of infected RBC obtained with rabbit anti-octapeptide antibodies, similarly isolated by affinity chromatography, was readily inhibited at low concentrations ofnative octapeptide or octapeptide-BSA (2 ,tg of octapeptide per ml).
In immunoblotting, the eluted human antibodies gave a strong staining of Pf 155 and weak staining of a few components of lower molecular weight (including the Mr 135,000 and Mr 120,000 polypeptides), similar to that obtained with antibodies from the same individual but isolated by elution from monolayers of P. falciparum-infected RBC (10) or with rabbit anti-octapeptide antibodies (Fig. 2) . The amount of immunoglobulin (human or rabbit) eluted from a BSASepharose column was at most 1/10th of that eluted from the octapeptide-BSA columns, and the eluted immunoglobulins were not reactive in either the IF or the immunoblotting assay (not shown).
To investigate if the major peptide components in the octapeptide preparation displayed any major antigenic differences, antibodies from the human serum used above were adsorbed to Sepharose beads bearing BSA conjugates of either of the two major octapeptide fractions obtained by HPLC (HPLC peaks 1 and 3, respectively, in Fig. 1 ). The antibodies eluted from these adsorbents were used for probing in dot-immunoblotting with BSA conjugates of the peptides from each of the three different HPLC peaks. Both antibody preparations reacted at similar titers with all three peptide conjugates.
The IgG fraction of the Liberian serum Kinon efficiently inhibits reinvasion of RBC by P. falciparum merozoites in in vitro cultures. This inhibitory activity can be highly enriched by prior elution of the antibodies from monolayers of infected RBCs (11) . As shown by the results of a representative experiment given in Table 3 , the octapeptide-reactive anti- Proc. Natl. Acad. Sci. USA 83 (1986) bodies eluted from the octapeptide-BSA column also inhibited reinvasion completely, with a 50% inhibition titer of 3 Ag/ml (Table 3) . Immunoglobulin eluted from BSA control columns had no inhibitory effects (not shown). Passing of the Kinon serum three times over octapeptide-BSA columns depleted it of octapeptide-reactive antibodies as detected by dot-immunoblotting. Thereafter, the depleted serum was incubated on monolayers ofP.falciparum-infected RBC, and the bound antibodies were eluted with glycine buffer. These eluted antibodies had a reduced capacity by more than a factor of 10 to inhibit parasite reinvasion as compared with monolayer eluted antibodies tested before passage over the octapeptide column. The fraction depleted of anti-octapeptide reactive antibodies was also the least reactive one in the surface IF assay (Table 3) . Similar results were obtained with another Liberian serum (L-30, Table 2 ). The reinvasion inhibitory capacity of antibodies reactive with the octapeptide sequence of Pf 155 was also demonstrated with affinitypurified anti-octapeptide antibodies from the two rabbit antisera (Fig. 3) . These antibodies inhibited reinvasion to 100%, and their 50%o inhibition titers were 65 or 75 ug of IgG per ml, respectively. In contrast, the total immunoglobulin fraction of these sera gave a maximum of 30% inhibition at about 2-3 mg/ml. As for the human antibodies, a correlation was found between the reinvasion inhibition titers and the lowest concentration of IgG giving positive surface immunofluorescence. Thus, for the anti-octapeptide-TT antiserum, the end-point titers in the IF assay were 60 ttg/ml for the antibodies eluted from the octapeptide-BSA column and 600 ,ug/ml for the total IgG fraction.
DISCUSSION
Several tandem repeats of the octapeptide Glu-Glu-Asn-ValGlu-His-Asp-Ala, followed by tandem repeats of half of this sequence (Glu-Glu-Asn-Val), constitute the main components of a C-terminally located block ofconserved amino acid sequences in a Mr 155,000 P. falciparum antigen (15, 16) . In this study we demonstrate that antibodies made in rabbits against the octapeptide conjugated with carrier proteins react with native P. falciparum antigens in a variety of test systems. In addition, our results suggest that a significant portion of the anti-Pf 155 antibodies found in humans exposed to P. falciparum react with epitopes associated with the same octapeptide unit as was used to immunize the rabbits. The antibodies raised in rabbits with the octapeptide conjugated with two different carrier molecules gave very similar reactions. Although one ofthe rabbits had also formed antibodies directed against determinants created through modification of carrier protein residues by the coupling reagent GA (22) , the other had not, and for both sera the octapeptide specificity of the antibodies reacting with plasmodial antigens was (29) . Similarly, rabbit antibodies to synthetic peptides corresponding to two or four repeats of the 4-amino acid subunit, repeated 41 times in the CS-antigen of P.falciparum, reacted efficiently with the native protein in several assay systems (30) . Hence, both in the case of the CS antigen and Pf 155, the antibodies to repetitive epitopes seem to recognize continuous amino acid sequences in the molecules.
Pf 155 has been shown to bind to glycophorin (9, 13, 14) and is assumed to play a role in the merozoite-RBC interactions resulting in RBC invasion (10) . This role is supported by the strong reinvasion inhibitory activity in vitro of human anti-Pf 155 antibodies (11, 13) . The present experiments show that the octapeptide-reactive fraction of these antibodies is very efficient in inhibiting reinvasion. In fact, these antibodies appear to be more efficient inhibitors than the antibodies eluted from the surface of infected RBC but depleted of the octapeptide reactive fraction. The importance of octapeptide-associated antigenic sites for the function of Pf 155 and related molecules in RBC invasion is also supported by the inhibitory effects of rabbit anti-octapeptide antibodies enriched by elution from the octapeptide-BSA immunoadsorbent. As was to be expected, the rabbit antibodies were less-efficient inhibitors than the corresponding human antibodies. Nevertheless, our results are similar to those obtained in the sporozoite system, where antibodies to synthetic peptides corresponding to the repeat regions of the CS antigen have been shown to inhibit the interaction of the sporozoites with their target cells in vitro and to neutralize sporozoite infectivity (30) (31) (32) . However, the inhibitory effect of the octapeptide-reactive antibodies on RBC infection in vivo remains to be established. As these antibodies occur in relatively large amounts in certain human sera and can be isolated by affinity chromatography, their possible protective efficiency in vivo can be assessed by passive immunization.
In conclusion, we have demonstrated that the C-terminal repeats of Pf 155 constitute an immunodominant region that might include target sites for a protective humoral immune response to asexual blood stages of P. falciparum. It is of importance to note that this region seems to be conserved, as no major antigenic diversity between different isolates or strains of P. falciparum has thus far been detected (refs. 10, 11, 13, 15, and 16; H.P., unpublished data). Hence, the antigen stands out as a suitable vaccine candidate, and synthetic peptides corresponding to the major epitopes of this molecule may be proper components of such a vaccine. Gene constructs coding for multiple repeat subunits of the sequences studied here may provide an alternative source of this material (33) .
